Le Doussal; Jean-Marc

Patent Applications and Registrations

Patent applications and USPTO patent grants for Le Doussal; Jean-Marc.The latest application filed is for "use of antibody against o-acetylated gd2 ganglioside to improve the therapeutic potential of drugs".

Company Profile

6.9.8

Le Doussal; Jean-Marc - Lausane CH
Le Doussal; Jean-Marc - Nantes FR
Le Doussal; Jean-Marc - Lausanne CH
Le Doussal; Jean-Marc - Paris Cedex FR
Le Doussal; Jean-Marc - Marseilles FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2) Grant 11,440,968 - Terme , et al. September 13, 2	2022-09-13
Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells cancer Grant 10,745,489 - Birkle , et al. A	2020-08-18
Human IgG1 derived antibody with pro-apoptotic activity Grant 10,669,328 - Dorvillius , et al.	2020-06-02
Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activity Grant 10,611,848 - Le Doussal , et al.	2020-04-07
Use Of Antibody Against O-acetylated Gd2 Ganglioside To Improve The Therapeutic Potential Of Drugs App 20190375853 - BIRKLE; Stephane ; et al.	2019-12-12
Humanized Antibody Against O-acetylated Gd2 Ganglioside (oacgd2) App 20190233537 - TERME; Mickael ; et al.	2019-08-01
Targeting O-acetylated Gd2 Ganglioside As A New Therapeutic And Diagnostic Strategy For Cancer Stem Cells Cancer App 20190023808 - BIRKLE; Stephane ; et al.	2019-01-24
Cosmetic composition comprising a muconopeptide Grant 10,149,812 - Stocklin , et al. Dec	2018-12-11
Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strategy for cancer stem cells cancer Grant 10,000,575 - Birkle , et al. June 19, 2	2018-06-19
Cosmetic Composition Comprising A Muconopeptide App 20170157016 - STOCKLIN; Reto ; et al.	2017-06-08
Cosmetic composition comprising a muconopeptide Grant 9,566,227 - Stocklin , et al. February 14, 2	2017-02-14
Human Igg1 Derived Antibody With Pro-apoptotic Activity App 20160280765 - DORVILLIUS; Mylene ; et al.	2016-09-29
Antibody Against Gd2-o-acetylated Ganglioside With Pro-apoptotic Activity App 20160272722 - LE DOUSSAL; Jean-Marc ; et al.	2016-09-22
Cosmetic Composition Comprising A Muconopeptide App 20150132235 - Stocklin; Reto ; et al.	2015-05-14
Method for the oligomerisation of peptides App 20100105876 - Terskikh; Alexey ; et al.	2010-04-29
Hydrophilic derivatives, their application to diagnosis and to therapeutics, diagnostic or therapeutic kits and immunological reagents Grant 5,274,076 - Barbet , et al. December 28, 1	1993-12-28
Affinity enhancement immunological reagents for in vivo detection and killing of specific target cells Grant 5,256,395 - Barbet , et al. October 26, 1	1993-10-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.